Melatonin in assisted reproductive technology: A pilot double-blind randomized placebo-controlled clinical trial

Frontiers in Endocrinology

Volumn 9, Issue SEP, 2018, Pages

  Fernando, Shavi ^a,b   Wallace, Euan Morrison ^a,b   Vollenhoven, Beverley ^a,c   Lolatgis, Nicholas ^c   Hope, Nicole ^c   Wong, Melissa ^c   Lawrence, Mark ^c   Lawrence, Anthony ^c   Russell, Chris ^c   Leong, Kenneth ^c   Thomas, Philip ^c   Rombauts, Luk ^a,c  

^a MONASH UNIVERSITY   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c MONASH IVF   (Australia)

Author keywords

ART; Assisted reproductive technology; Clinical pregnancy; In vitro fertilization; IVF; Melatonin

Indexed keywords

ESTRADIOL; LUTEINIZING HORMONE; MELATONIN; PLACEBO; PROGESTERONE;

ADULT; ARTICLE; AUSTRALIA; CLINICAL OUTCOME; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; EMBRYO; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; HEADACHE; HUMAN; INFERTILITY; INFERTILITY THERAPY; INTENTION TO TREAT ANALYSIS; LIVE BIRTH; MAJOR CLINICAL STUDY; OOCYTE RETRIEVAL; OVARY FOLLICLE FLUID; PILOT STUDY; PLACENTA PREVIA; PREECLAMPSIA; PREGNANCY RATE; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SPONTANEOUS ABORTION;

EID: 85055133367     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2018.00545     Document Type: Article

References (27)

1. Guerin P, El Mouatassim S, Menezo Y. Oxidative stress and protection against reactive oxygen species in the pre-implantation embryo and its surroundings. Hum Reprod Update (2001) 7:175-89. doi: 10.1093/humupd/7.2.175
2. Tamura H, Takasaki A, Miwa I, Taniguchi K, Maekawa R, Asada H, et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res. (2008) 44:280-7. doi: 10.1111/j.1600-079X.2007.00524.x
3. Tamura H, Takasaki A, Taketani T, Tanabe M, Kizuka F, Lee L, et al. The role of melatonin as an antioxidant in the follicle. J Ovarian Res. (2012) 5:5. doi: 10.1186/1757-2215-5-5
4. Batioǧlu A, Şahin U, Gürlek B, Öztürk N, Ünsal E. The efficacy of melatonin administration on oocyte quality. Gynecol Endocrinol. (2012) 28:91-3. doi: 10.3109/09513590.2011.589925
5. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. (2005) 3:28. doi: 10.1186/1477-7827-3-28
6. Abecia JA, Palacin I, Forcada F, Valares JA. The effect of melatonin treatment on the ovarian response of ewes to the ram effect. Domest Anim Endocrinol. (2006) 31:52-62. doi: 10.1016/j.domaniend.2005.09.003
7. Rodriguez-Osorio N, Kim I, Wang H, Kaya A, Memili E. Melatonin increases cleavage rate of porcine preimplantation embryos in vitro. J Pineal Res. (2007) 43:283-8. doi: 10.1111/j.1600-079X.2007.00475.x
8. Sanchez-Barcelo EJ, Mediavilla MD, Tan DX, Reiter RJ. Clinical uses of melatonin: evaluation of human trials. Curr Med Chem. (2010) 17:2070-95. doi: 10.2174/092986710791233689
9. Dholpuria S, Vyas S, Purohit GN, Pathak KML. Sonographic monitoring of early follicle growth induced by melatonin implants in camels and the subsequent fertility. J Ultrasound (2012) 15:135-41. doi: 10.1016/j.jus.2012.02.008
10. Sampaio R, Conceição S, Miranda M, Sampaio Lde F, Ohashi O. MT3 melatonin binding site, MT1 and MT2 melatonin receptors are present in oocyte, but only MT1 is present in bovine blastocyst produced in vitro. Reprod Biol Endocrinol. (2012) 10:103. doi: 10.1186/1477-7827-10-103
11. Eryilmaz O, Devran A, Sarikaya E, Aksakal F, Mollamahmutoglu L, Cicek N. Melatonin improves the oocyte and the embryo in IVF patients with sleep disturbances, but does not improve the sleeping problems. J Assist Reprod Genet. (2011) 28:815-20. doi: 10.1007/s10815-011-9604-y
12. Nishihara T, Hashimoto S, Ito K, Nakaoka Y, Matsumoto K, Hosoi Y, Morimoto Y. Oral melatonin supplementation improves oocyte and embryo quality in women undergoing in vitro fertilization-embryo transfer. Gynecol Endocrinol. (2014) 30, 359-62. doi: 10.3109/09513590.2013.879856
13. Yie SM, Brown GM, Liu GY, Collins JA, Daya S, Hughes EG, et al. Melatonin and steroids in human pre-ovulatory follicular fluid: seasonal variations and granulosa cell steroid production. Hum Reprod. (1995) 10:50-5. doi: 10.1093/humrep/10.1.50
14. Lord T, Nixon B, Jones KT, Aitken RJ. Melatonin prevents postovulatory oocyte aging in the mouse and extends the window for optimal fertilization in vitro. Biol Reprod. (2013) 88:67. doi: 10.1095/biolreprod.112.106450
15. Pacchiarotti A, Carlomagno G, Unfer V, Frati P, Pacchiarotti A, Prapas N. Role of Myo-inositol and melatonin supplementation in follicular fluid of IVF patients with polycystic ovarian syndrome: a randomized controlled trial. Clin Trialsgov. (2013).
16. Waldhauser F, Waldhauser M, Lieberman HR, Deng MH, Lynch HJ, Wurtman RJ. Bioavailability of oral melatonin in humans. Neuroendocrinology (1984) 39:307-13. doi: 10.1159/000123997
17. Unfer V, Raffone E, Rizzo P, Buffo S. Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study. Gynaecol Endocrinol. (2011) 27:857-61. doi: 10.3109/09513590.2011.564687
18. Van Teijlingen E, Hundley V. The importance of pilot studies. Nurs Stand. (2002) 16:33-6. doi: 10.7748/ns.16.40.33.s1
19. Fernando S, Osianlis T, Vollenhoven B, Wallace E, Rombauts L. A pilot double-blind randomised placebo-controlled dose-response trial assessing the effects of melatonin on infertility treatment (MIART): study protocol. BMJ Open (2014) 4:e005986. doi: 10.1136/bmjopen-2014-005986
20. Altman D, Bland J. Treatment allocation by minimisation. BMJ (2005) 330:843. doi: 10.1136/bmj.330.7495.843
21. Fernando S, Biggs SN, Horne RSC, Vollenhoven B, Lolatgis N, Hope N, et al. The impact of melatonin on the sleep patterns of women undergoing IVF: a double blind RCT. Hum Reprod Open (2017) 2017: hox027. doi: 10.1093/hropen/hox027
22. Ressmeyer A, Mayo J, Zelosko V, Sáinz R, Tan D, Poeggeler B, et al. Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. Redox Rep. (2003) 8:205-13. doi: 10.1179/135100003225002709
23. Gooneratne NS, Edwards AY, Zhou C, Cuellar N, Grandner MA, Barrett JS. Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults. J Pineal Res. (2012) 52:437-45. doi: 10.1111/j.1600-079X.2011.00958.x
24. Basini G, Bussolati S, Ciccimarra R, Grasselli F. Melatonin potentially acts directly on swine ovary by modulating granulosa cell function and angiogenesis. Reprod Fertil Dev. (2017) 29:2305-12. doi: 10.1071/RD16513
25. Tong J, Sheng S, Sun Y, Li H, Li WP, Zhang C, et al. Melatonin levels in follicular fluid as markers for IVF outcomes and predicting ovarian reserve. Reproduction (2017) 153:443-51. doi: 10.1530/REP-16-0641
26. Barnett AG, Van Der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol. (2005) 34:215-20. doi: 10.1093/ije/dyh299
27. Pacchiarotti A, Carlomagno G, Antonini G, Pacchiarotti A. Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome. Gynecol Endocrinol. (2016) 32:69-73. doi: 10.3109/09513590.2015.1101444